While CD4reg populations are consistently enriched in tumor compared to adjacent non-malignant tissue, anti-PD-L1 therapy results in enrichment of a specific CD4cyto population in treated tumor compared to treated non-malignant tissue, which is not enriched in untreated bladder tumors. This evidence concerns the gene CD274 and neoplasm.